| # | Drug | Count |
|---|---|---|
| 0 | DARATUMUMAB | 2 |
| 1 | BELANTAMAB MAFODOTIN | 1 |
| 2 | BENDAMUSTINE HYDROCHLORIDE | 1 |
| 3 | BORTEZOMIB | 1 |
| 4 | CAPECITABINE | 1 |
| 5 | CYCLOPHOSPHAMIDE | 1 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1 |
| 8 | DEXAMETHASONE | 1 |
| 9 | DEXAMETHASONE 1.5 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELANTAMAB MAFODOTIN | 1 | 0.0003 |
| 1 | MARC GLASSMAN | 1 | 0.0003 |
| 2 | DOCUSATE SODIUM AND SENNOSIDES | 1 | 0.0002 |
| 3 | DOCUSATE CALCIUM | 1 | 0.0002 |
| 4 | DOCUSATE SODIUM SENNOSIDES | 1 | 0.0002 |
| 5 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 6 | THALIDOMIDE | 1 | 0.0000 |
| 7 | FERROUS SULFATE | 1 | 0.0000 |
| 8 | DOCUSATE SODIUM | 1 | 0.0000 |
| 9 | OXALIPLATIN | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 1 |
| 1 | Corticosteroid [EPC] | 1 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 1 |
| 3 | Platinum-based Drug [EPC] | 1 |
| 4 | Proteasome Inhibitor [EPC] | 1 |
| 5 | Thalidomide Analog [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Thalidomide Analog [EPC] | 1 | 0.0000 |
| 5 | Corticosteroid [EPC] | 1 | 0.0000 |